Kyverna Therapeutics, Inc. (KYTX)
NASDAQ·Healthcare·Biotechnology
$5.10
+4.51%
Mkt Cap $301.80M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+390.2%
Consensus $25.00 vs current $5.10
NASDAQ·Healthcare·Biotechnology
$5.10
+4.51%
Mkt Cap $301.80M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$25.00
Range $25.00 – $25.00
+390.2%
Consensus $25.00 vs current $5.10